System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Sara Gandini is an expert in Oncology at European Institute of Oncology (Italy). As of October 2026, ScienceLeadR ranks Sara Gandini in the top 1% of experts worldwide for Melanoma, Skin Neoplasms and Breast Diseases. Sara Gandini has authored 600 publications, the most recent in 2026, and is an investigator in 16 clinical trials, 4 of them ongoing. SLR score: 1,971 (community average: 125). How the SLR is computed.

LeadR Profile

Sara Gandini European Institute of Oncology Italy
1 971 ScienceLeadR Reputation 1971

Unlock

Register Login
Network Map

Oncology

Subspecialties: Radiotherapy - Public Health - Dermatology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1997 - 2026
Source: PubMed

European Institute of Oncology

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 600

Citations

Citations: 24 503 1st author: 41 Last author: 97 Unique author: 3

Main journals

Radiother Oncol 46
Eur J Cancer 29
Cancers (Basel) 27
J Clin Oncol 26
Cancer Res 23

Best Journals

J Clin Oncol 8
Ann Oncol 5
Nat Med 3

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Combined pharmacologic and lifestyle intervention for breast cancer prevention: Results of the randomized phase II TOLERANT trial in high-risk women.
PMID 42892237 — quality of life, life style, breast neoplasms, neoplasms, biomarkers, breast		Eur J Cancer20260
Non-pharmacological interventions: nomenclature, taxonomy, and working definitions.
PMID 42881242 — pharmaceutical preparations, public health, pandemics		J Public Health Policy20260
Benefits and Harms of Herbal Medicines for Preventing and Treating Acute Respiratory Infections: An Overview of Systematic Reviews.
PMID 42839197 — respiratory tract infections, drug-related side effects and adverse reactions, plants, medicinal, therapeutics, herbal medicine, infections		Phytother Res20260
Second ipsilateral locoregional recurrence in patients with hormone receptor-positive, HER2-negative breast cancer: a cohort study.
PMID 42729525 — lymph nodes, breast neoplasms, neoplasms, cohort studies, hormones, lymph, breast		EClinicalMedicine20260
SHBG as a breast cancer risk biomarker in premenopausal women? Results from an individual patient's pooled analysis and a meta-analysis.
PMID 42726095 — breast neoplasms, neoplasms, biomarkers, breast		J Natl Cancer Inst20260

Clinical Studies 16

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 11
Phase 2 4
Phase 3 1

By status:

Completed 8
Recruiting 5
Active not recruiting 3

By type:

Interventional 12
Observational 4

By Monocentric/Multicentric:

monocentric 10
multicentric2to4 3
multicentric5to9 3
multicentricup10 0

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

4 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
MONDRIAN Multi omics Integrative Modelling for Stereotactic Body Radiotherapy in Early stage Non small Cell Lung Cancer
NCT05974475 — radiotherapy, cells, radiation tolerance, comorbidity, genomics, lung, lymph nodes, neoplasms, multiple chronic conditions, carcinoma, non-small-cell lung, prescriptions, mastectomy, segmental, lung neoplasms, lymph, small cell lung carcinoma, proteomics, therapeutics, dissection, carcinoma		N/ARecruiting2023
Health Care Workers Cohort Study in the EuCARE Project (EuCARE HCW)
NCT05534009 — immunization, vaccines, cohort studies, respect, vaccination, covid-19, immunity, diagnosis, records, infections		N/ARecruiting2022
Intervention Study in Prostate Cancer Patients Undergoing Radiotherapy
NCT05155618 — radiotherapy, exercise, physical therapists, life style, healthy lifestyle, neoplasms, health status, prostate, diet, prostatic neoplasms, microbiota		N/AActive not recruiting2021
Single Fraction Preoperative Radiotherapy for Early Stage Breast Cancer
NCT04679454 — radiotherapy, breast neoplasms, radiosurgery, polymerase chain reaction, neoplasms, breast, maximum tolerated dose, therapeutics		N/ARecruiting2021

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS